AptaDB: a comprehensive database integrating aptamer–target interactions
RNA · 2024-03 · 30 (3) · 189-199
DOI: 10.1261/rna.079784.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 19.12.2023. Verfasst von Long Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East…. Hauptthemen laut MEDLINE: Oligonucleotides, Aptamers, Nucleotide. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism.
Abstract (Originalsprache)
Aptamers have emerged as research hotspots of the next generation due to excellent performance benefits and application potentials in pharmacology, medicine, and analytical chemistry. Despite the numerous aptamer investigations, the lack of comprehensive data integration has hindered the development of computational methods for aptamers and the reuse of aptamers. A public access database named AptaDB, derived from experimentally validated data manually collected from the literature, was hence developed, integrating comprehensive aptamer-related data, which include six key components: (i) experimentally validated aptamer–target interaction information, (ii) aptamer property information, (iii) structure information of aptamer, (iv) target information, (v) experimental activity information, and (vi) algorithmically calculated similar aptamers. AptaDB currently contains 1350 experimentally validated aptamer–target interactions, 1230 binding affinity constants, 1293 aptamer sequences, and more. Compared to other aptamer databases, it contains twice the number of entries found in available databases. The collection and integration of the above information categories is unique among available aptamer databases and provides a user-friendly interface. AptaDB will also be continuously updated as aptamer research evolves. We expect that AptaDB will become a powerful source for aptamer rational design and a valuable tool for aptamer screening in the future. For access to AptaDB, please visit http://lmmd.ecust.edu.cn/aptadb/ .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China yt…
ORCID-Profile: Zengrui Wu, Weihua Li, Guixia Liu, Yun Tang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism
Zitieren
APA
Chen, L., Yu, Z., Wu, Z., Zhou, M., Wang, Y., Yu, X., Li, W., Liu, G., & Tang, Y. (2024). AptaDB: a comprehensive database integrating aptamer–target interactions. RNA, 30(3), 189-199. https://doi.org/10.1261/rna.079784.123
Vancouver
Chen L, Yu Z, Wu Z, Zhou M, Wang Y, Yu X, et al. AptaDB: a comprehensive database integrating aptamer–target interactions. RNA. 2024;30(3):189-199. doi:10.1261/rna.079784.123
BibTeX
@article{Chen2024,
author = {Chen, Long and Yu, Zhuohang and Wu, Zengrui and Zhou, Moran and Wang, Yimeng and Yu, Xinxin and Li, Weihua and Liu, Guixia and Tang, Yun},
title = {AptaDB: a comprehensive database integrating aptamer–target interactions},
journal = {RNA},
year = {2024},
volume = {30},
number = {3},
pages = {189--199},
doi = {10.1261/rna.079784.123}
}
EUVIMED